2,218 Shares in Intuitive Surgical, Inc. (NASDAQ:ISRG) Purchased by FourThought Financial Partners LLC

FourThought Financial Partners LLC bought a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 2,218 shares of the medical equipment provider’s stock, valued at approximately $1,158,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Berbice Capital Management LLC acquired a new stake in shares of Intuitive Surgical in the 4th quarter valued at approximately $26,000. BankPlus Trust Department bought a new position in Intuitive Surgical in the fourth quarter valued at approximately $28,000. MidAtlantic Capital Management Inc. bought a new stake in Intuitive Surgical in the 3rd quarter valued at $33,000. Decker Retirement Planning Inc. bought a new stake in shares of Intuitive Surgical in the fourth quarter valued at about $36,000. Finally, Capital Performance Advisors LLP acquired a new position in Intuitive Surgical during the 3rd quarter worth approximately $38,000. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Trading Down 0.1 %

Shares of ISRG stock opened at $591.01 on Tuesday. The stock has a market capitalization of $210.51 billion, a P/E ratio of 92.20, a PEG ratio of 5.85 and a beta of 1.39. The firm’s 50 day moving average is $566.43 and its 200 day moving average is $526.49. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00.

Insider Transactions at Intuitive Surgical

In related news, Director Amal M. Johnson sold 4,635 shares of the company’s stock in a transaction that occurred on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the transaction, the director now directly owns 12,275 shares in the company, valued at approximately $6,955,015. This represents a 27.41 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Robert Desantis sold 376 shares of Intuitive Surgical stock in a transaction on Friday, November 29th. The stock was sold at an average price of $539.00, for a total transaction of $202,664.00. Following the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,967,734. This represents a 6.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 6,240 shares of company stock valued at $3,529,040. 0.90% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

ISRG has been the subject of a number of analyst reports. Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. Citigroup raised their target price on shares of Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research note on Friday, January 24th. Piper Sandler reaffirmed an “overweight” rating and issued a $670.00 target price (up previously from $538.00) on shares of Intuitive Surgical in a research report on Friday, January 24th. Barclays lifted their target price on Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. Finally, JPMorgan Chase & Co. increased their target price on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have given a buy rating to the company’s stock. Based on data from MarketBeat, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus price target of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.